BioPlus Acquisition Corp. Unit
BIOSU
BIOSU was delisted on the 6th of October, 2023.
24 hedge funds and large institutions have $33.6M invested in BioPlus Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 9 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
20% less funds holding
Funds holding: 30 → 24 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
82% less capital inflows, than outflows
Capital inflows: $1.63M | Capital outflows: $9.15M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
+$592K |
| 2 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$547K |
| 3 |
FLC
Fifth Lane Capital
Austin,
Texas
|
+$300K |
| 4 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$101K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$52.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$4M |
| 2 |
Millennium Management
New York
|
-$1.35M |
| 3 |
JP Morgan Chase
New York
|
-$1.04M |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$999K |
| 5 |
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$499K |
BIOSU Hedge Fund Activity: Q2 2022 in Review
24 of the 5,962 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q2 2022, worth a combined $33.6M — down 13% from $38.8M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BIOSU and 3 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Schechter Investment Advisors, adding an estimated $592K. The largest seller was Mangrove Partners, exiting entirely with an estimated $4M sold.
- 24 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q2 2022, down from 30 in Q1 2022.
- Funds reported $33.6M of BioPlus Acquisition Corp. Unit stock for Q2 2022, down 13% quarter-over-quarter.
- 3 funds opened new BioPlus Acquisition Corp. Unit positions in Q2 2022 and 9 closed out, a net change of -6 holders.
- The largest BioPlus Acquisition Corp. Unit buyer in Q2 2022 was Schechter Investment Advisors, an estimated $592K added.
- The largest BioPlus Acquisition Corp. Unit seller in Q2 2022 was Mangrove Partners, an estimated $4M sold.
Based on aggregated 13F filings for Q2 2022.